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The pharmacological properties of slow Ca
 
2
 
 
 
-activated K
 
 
 
 current (K
 
slow
 
) were investigated in mouse pancreatic
 
 
 
-cells and islets to understand how K
 
slow
 
 contributes to the control of islet bursting, [Ca
 
2
 
 
 
]
 
i
 
 oscillations, and insulin
secretion. K
 
slow
 
 was insensitive to apamin or the K
 
ATP
 
 channel inhibitor tolbutamide, but UCL 1684, a potent and
selective nonpeptide SK channel blocker reduced the amplitude of K
 
slow
 
 tail current in voltage-clamped mouse
 
 
 
-cells. K
 
slow
 
 was also selectively and reversibly inhibited by the class III antiarrythmic agent azimilide (AZ). In
isolated 
 
 
 
-cells or islets, pharmacologic inhibition of K
 
slow
 
 by UCL 1684 or AZ depolarized 
 
 
 
-cell silent phase
potential, increased action potential ﬁring, raised [Ca
 
2
 
 
 
]
 
i
 
, and enhanced glucose-dependent insulin secretion. AZ
inhibition of K
 
slow
 
 also supported mediation by SK, rather than cardiac-like slow delayed rectiﬁer channels since
bath application of AZ to HEK 293 cells expressing SK3 cDNA reduced SK current. Further, AZ-sensitive K
 
slow
 
current was extant in 
 
 
 
-cells from KCNQ1 or KCNE1 null mice lacking cardiac slow delayed rectiﬁer currents.
These results strongly support a functional role for SK channel-mediated K
 
slow
 
 current in 
 
 
 
-cells, and suggest that
drugs that target SK channels may represent a new approach for increasing glucose-dependent insulin secretion.
The apamin insensitivity of 
 
 
 
-cell SK current suggests that 
 
 
 
-cells express a unique SK splice variant or a novel
heteromultimer consisting of different SK subunits.
 
INTRODUCTION
 
When exposed to glucose concentrations 
 
 
 
7 mM,
pancreatic islets of Langerhans exhibit electrical oscilla-
tions consisting of bursts of fast Ca
 
2
 
 
 
-dependent action
potentials riding upon slower depolarizing plateaus
(Dean and Matthews, 1970a; Ashcroft and Rorsman,
1989; Cook et al., 1991; Satin and Smolen, 1994). The
period of this bursting typically ranges from tens of
seconds to minutes in 11.1 mM glucose, and numerous
studies have shown that bursting leads to concomitant
oscillations in islet [Ca
 
2
 
 
 
]
 
i
 
 that drive insulin secretion
(Bergsten et al., 1994; Barbosa et al., 1998; Zhang et
al., 2003). However, despite extensive investigation, the
ionic basis of islet pacemaking is not fully understood.
The cyclic activation of a Ca
 
2
 
 
 
-activated K
 
 
 
 current
(K
 
Ca
 
) has been a strong candidate pacemaker (Atwater
et al., 1979; Satin and Smolen, 1994; Sherman, 1996),
and in support of this, islet bursting is simulated by
models incorporating the cyclic activation and deactiva-
tion of K
 
Ca
 
 channels by bursting-induced elevations in
[Ca
 
2
 
 
 
]
 
i
 
 (Chay and Keizer, 1983). Göpel et al. (1999)
presented evidence that K
 
slow
 
, a novel slow Ca
 
2
 
 
 
-activated
K
 
 
 
 current, tracks [Ca
 
2
 
 
 
]
 
i
 
 as it rises in response to a
voltage clamp command designed to mimic an islet
burst. Unlike the fast or “BK type” K
 
Ca
 
 channels of 
 
 
 
-cells
(Kukuljan et al., 1991), K
 
slow
 
 was insensitive to charyb-
dotoxin or low concentrations of TEA (Göpel et al.,
1999; Hennige et al., 2000), but was regulated by both
store and cytoplasmic Ca
 
2
 
 
 
 (Goforth et al., 2002). In
contrast to their initial description of the current (Gö-
pel et al., 1999), Kanno et al. (2002) suggested that
K
 
slow
 
 might be a mosaic of K
 
ATP
 
 and Ca
 
2
 
 
 
-activated K
 
 
 
current. More recently, Tamarina et al. (2003) conﬁrmed
that small-conductance calcium-activated K
 
 
 
 channels
(SK type) are expressed in pancreatic islets, and sug-
gested these channels regulate glucose-induced [Ca
 
2
 
 
 
]
 
i
 
oscillations in islets by mediating K
 
slow
 
. However, a
problem with this hypothesis is that apamin, the canon-
ical SK blocker in other systems, does not affect mouse
islet bursting or 
 
 
 
-cell K
 
slow
 
 current (Lebrun et al., 1983;
Ämmälä et al., 1993; Göpel et al., 1999; Goforth et al.,
2002). Thus, it is not yet proven that SK channels medi-
ate K
 
slow
 
 current in 
 
 
 
-cells. The lack of a selective K
 
slow
 
blocker has further hampered progress in determining
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the function role of K
 
slow
 
 current in islet electrophysiol-
ogy and stimulus–secretion coupling.
We now report that UCL 1684, a highly selective,
nonpeptidergic blocker of SK channels (Rosa et al.,
1998), or azimilide (NE-10064, (E)-1-[[[5-(4-chlo-
rophenyl)-2-furanyl]methylene]amino]-3-[4-(4-methyl-
1-piperazinyl)butyl]-2,4-imidazolidinedione dihydro-
chloride, AZ), a novel class III antiarrhythmic agent,
inhibit K
 
slow
 
 in mouse pancreatic 
 
 
 
-cells or islets. In car-
diac cells, AZ blocks both the slowly (I
 
Ks
 
) and rapidly
activating (I
 
Kr
 
) components of delayed rectiﬁer potas-
sium current and as a result prolongs cardiac refractori-
ness (Busch et al., 1994; Fermini et al., 1995; Salata and
Brooks, 1997; Karam et al., 1998). In islets, however,
K
 
slow
 
 blockade by AZ was due to block of Ca
 
2
 
 
 
-activated
SK channels because we found that, on the one hand,
AZ was effective in blocking K
 
slow
 
 even in 
 
 
 
-cells from
mice in which I
 
Ks
 
 was eliminated by two different global
knockouts, and on the other hand, AZ blocked SK3
channels expressed in transfected HEK 293 cells. In
terms of function, suppression of K
 
slow
 
 by UCL 1684 or
AZ resulted in membrane depolarization, increased ac-
tion potential ﬁring, and a concomitant increase in is-
let 
 
 
 
-cell [Ca
 
2
 
 
 
]
 
i
 
. In islets exhibiting regular [Ca
 
2
 
 
 
]
 
i
 
oscillations in 11.1 mM glucose (Zhang et al., 2003),
UCL or AZ increased [Ca
 
2
 
 
 
]
 
i
 
 as well as oscillation fre-
quency. Furthermore, both K
 
slow
 
 blockers signiﬁcantly
enhanced glucose-dependent insulin release, while not
affecting basal secretion.
 
MATERIALS AND METHODS
 
Culture of Islets and Islet 
 
 
 
-Cells
 
Mouse islets were isolated from the pancreases of Swiss-Webster
mice by collagenase digestion (Zhang et al., 2003). Islets were
dispersed into single cells by gently shaking the islets in a low-cal-
cium solution. Islets or 
 
 
 
-cells were seeded on glass coverslips in
35-mm Petri plates and cultured in RPMI-1640 medium with 11.1
mM glucose, FBS, 
 
l
 
-glutamine, and penicillin/streptomycin (In-
vitrogen). All cultures were kept at 37
 
 
 
C in an air/CO
 
2
 
 incubator.
Cells were fed every 2–3 d, and were kept in vitro for up to 5 d,
while islets were typically cultured for 1–2 d.
 
Electrophysiology
 
 
 
-cells or islets were superfused with a standard external solution
containing (in mM) 115 NaCl, 3 CaCl
 
2
 
, 5 KCl, 2 MgCl
 
2
 
, 10
HEPES, 11.1 glucose (pH 7.2). The perforated patch-clamp tech-
nique was used to record islet or 
 
 
 
-cell membrane potentials or
ion currents. Pipettes were pulled from borosilicate glass using a
two-stage horizontal puller (P-97, Sutter Instruments). Pipette
tips were ﬁlled with an internal solution containing (in mM) 28.4
K
 
2
 
SO
 
4
 
, 63.7 KCl, 11.8 NaCl, 1 MgCl
 
2
 
, 20.8 HEPES, 0.5 EGTA (pH
7.2) and then backﬁlled with internal solution plus 0.1 mg/
ml amphotericin B. An Axopatch-200B patch-clamp ampliﬁer
(Axon Instruments) was used in the standard tight-seal perfo-
rated patch-clamp mode to record membrane potentials or ion
currents in current or voltage clamp mode, respectively (Hamill
et al., 1981). Pipette resistances ranged from 5 to 8 M
 
 
 
 using our
internal solutions, while seal resistances ranged from 2 to 10 G
 
 
 
.
Solutions were applied to 
 
 
 
-cells or islets using a gravity-driven
perfusion system, which allowed switching between multiple res-
ervoirs and ﬂow rates in excess of 1 ml/min. All experiments
were performed at 32
 
 
 
C–35
 
 
 
C using a feedback-controlled tem-
perature regulation system (CellMicro Controls). All drugs were
made up fresh daily from frozen stock solutions. Drugs and
chemicals were obtained from Sigma-Aldrich with the exception
of AZ and HMR1556, which were a gift from G.N. Tseng (VCU,
Richmond, VA).
 
[Ca
 
2
 
 
 
]
 
i
 
 Measurements
 
Cultured mouse islets were loaded with the Ca
 
2
 
 
 
-sensitive dye,
fura-2/AM (Invitrogen). 2 
 
 
 
mol/l fura-2-AM and 1 
 
 
 
l of 2.5%
pluronic acid were added to cells in 35-mm culture dishes con-
taining 1 ml of medium, and islets were incubated for 30 min at
37
 
 
 
C to load with dye. After loading, islets were washed once and
then incubated in standard external solution for 20 min. [Ca
 
2
 
 
 
]
 
i
 
was measured by placing islets in a small recording chamber
mounted on the stage of an Olympus IX-50 inverted epiﬂuores-
cence microscope (Olympus). Fura-2 was excited at 340/380 nm
using a galvanometer-driven mirror that alternated a light beam
from a xenon source (“HyperSwitch,” IonOptix Corporation). A
photomultiplier and photon counting were used to quantify fura-2
emission at 510 nm (IonOptix Inc.). Fluorescence data were ac-
quired and analyzed using IonWizard software (IonOptix).
[Ca
 
2
 
 
 
]
 
i values were determined from the ﬂuorescence ratio
(R) of Ca2 -bound fura-2 (excited at 340 nm) to unbound fura-2
(excited at 380 nM). Absolute [Ca2 ]i was determined using a
standard equation (Grynkiewicz et al., 1985). To convert R to
[Ca2 ]i using this equation, Rmax and Rmin were obtained by ex-
posing islets to 10  M ionomycin plus 3 mM Ca2  or 10 mM
EGTA, respectively, at the end of each experiment. The equilib-
rium constant for Ca2  binding to fura-2 (Kd) was assumed to be
224 nM (Grynkiewicz et al., 1985).
Measurement of Insulin Secretion
Islets were cultured overnight and then washed twice with our
standard external saline containing 11.1 mM glucose. Following
this, each dish containing 10 islets was incubated for 60 min in 1
ml of standard external solution containing various concentra-
tions of glucose, UCL 1684, or AZ. A portion of the reaction solu-
tion was withdrawn at the end of the incubation period and di-
luted appropriately for insulin assay. Insulin was measured using
an ELISA kit for detecting mouse insulin (Mercodia Ultrasensitive
Mouse Insulin ELISA Kit; Mercodia), according to the instructions
of the manufacturer. Sample absorbance at 450 nm was read using
a microplate reader (model 2550, Bio-Rad Laboratories). Data
were collected from four mice for UCL 1684 and four mice for AZ,
and the experiment was repeated three times. The content of insu-
lin in samples was calculated according to a standard curve.
Functional Expression of the hSK3 Gene in HEK 293
HEK 293 cells were cultured in minimal essential medium con-
taining glutamine and 10% FBS. 1 or 2 d before transfection, cells
were transferred to 35-mm Petri dishes and were grown to  70%
conﬂuence. A mixture containing 0.1  g of the plasmid DNA
encoding EGFP-N1 (BD Biosciences, CLONTECH Laboratories
Inc.) and 1  g of plasmid DNA encoding human SK3 (Kohler et
al., 1996; Chandy et al., 1998) was transfected into HEK 293 cells
using Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s protocol. Cells were studied 24–48 h after transfection.
SK3 currents were recorded using whole-cell patch clamp as
described in general above. The electrodes used contained 28.4
mM K2SO4, 63.7 mM KCl, 10.7 mM NaCl, 20.8 mM HEPES, 1 mM
MgCl2, 1 mM EGTA, 0.9 mM CaCl2, pH 7.2; the calculated
[Ca2 ]i for this solution was  1  M, which is sufﬁcient for nearlyZhang et al. 355
maximal activation of SK3 channels (Kohler et al., 1996). HEK
293 cells showing green ﬂuorescence in the bath solution (115
mM NaCl, 3 mM CaCl2, 5 mM KCl, 2 mM MgCl2, 10 mM HEPES,
11.1 mM glucose, pH 7.35) were selected for voltage clamping.
After the formation of a tight seal in cell-attached mode, the ex-
ternal solution was changed to an “SK blocking solution” (71 mM
NaCl, 5 mM KCl, 2 mM MgCl2, 10 mM BaCl2, 30 mM TEA-Cl, 10
mM HEPES, 11.1 mM glucose, pH 7.35), which contained Ba2 
and TEA to prevent SK current activation before establishing
whole cell mode to help preserve cell viability. Once whole cell
mode was established, SK3 currents were then initiated by using
a high K  external solution (90 mM NaCl, 30 mM KCl, 3 mM
CaCl2, 2 mM MgCl2, 10 mM HEPES, 11.1 mM glucose, pH 7.35)
and were recorded at  80 mV and  10 mV. The effects of UCL
1684 and AZ on SK3 currents were observed by adding these
drugs to the bathing solution.
Data analysis, curve ﬁtting, and graphics were performed us-
ing IgorPro Software (Wavemetrics) and statistical analysis and
curve ﬁtting of dose–response data was done using GraphPad
Prism Pro. Data shown are means   SEM. Where relevant, paired
or unpaired Student’s t tests were used to test for signiﬁcance. P
values  0.05 were considered signiﬁcant and denoted by * or #
in ﬁgures; P   0.01 are denoted by ** or ## in ﬁgures; and P  
0.001 are denoted by *** or ### in ﬁgures.
RESULTS
Kslow Current Is Inhibited by the SK Blocker UCL 1684 in 
Mouse Single  -Cells
Mouse islet cells and insulin-secreting cell lines express
SK channel isoforms, and SK channel modulators alter
glucose-dependent [Ca2 ]i oscillations in mouse islets
(Tamarina et al., 2003). Paradoxically, however, the
prototypical SK inhibitor apamin, which modulates
[Ca2 ]i oscillations in rodent islets (Tamarina et al.,
2003), does not block Kslow current in mouse  -cells
(Göpel et al., 1999; Goforth et al., 2002), and is without
effect on islet electrical bursting (Lebrun et al., 1983).
The reasons for these discrepancies are not clear. To
determine whether Kslow is indeed mediated by SK
channels, and to determine the role of Kslow in islet
stimulus–secretion coupling, we more fully character-
ized the pharmacological properties of Kslow current.
To elicit Kslow current, we used a standard protocol
consisting of a physiological waveform command that
resembled an islet burst to isolate a deactivation “tail”
of Kslow current. This protocol stepped membrane po-
tential from  65 to  40 mV for 5 s, followed by a 5-s
train of spike-like pulse depolarizations from  40 to 0
mV, and then a 10-s sojourn back to  40 mV (for more
details of the protocol used, see Göpel et al., 1999).
As shown in Fig. 1 A, upon application of the pulse
train, an envelope of slow outward current progressively
activated, with faster outward currents superposed, and
then slowly deactivated once the pulse train was termi-
nated. The peak amplitudes of the deactivating tail cur-
rents mediated by Kslow are denoted by arrows in the ﬁg-
ure, and were used to quantify the degree of Kslow activa-
tion (Göpel et al., 1999; Goforth et al., 2002).
As the bath application of up to 1  M apamin did not
block Kslow current (n     10, unpublished data), we
tested the potent nonpeptide SK blocker UCL 1684,
which is known to selectively target SK 1-3 type KCa
channels (Rosa et al., 1998). As shown in Fig. 1 B, 10 nM
UCL 1684 inhibited Kslow current. In 17 isolated  -cells,
the mean current density was reduced from 1.34   0.14
to 0.83   0.15 pA/pF (P   0.001). Kslow block by UCL
1684 was dose responsive, as shown in Fig. 1 C. The data
were ﬁt by a single binding site model to yield an IC50 of
6.2 nM and a Bmax of 54.1%. This IC50 is similar to the
sensitivity of SK channels to UCL 1684 in other systems
(Dunn, 1999; Malik-Hall et al., 2000; Hosseini et al.,
2001). The data are consistent with the hypothesis that
SK channels are at least partly involved in the mediation
of  -cell Kslow current. In a previous study, Kanno et al.
(2002) reported that Kslow was a composite of KCa and
KATP channels. In our hands, however, the Kslow current
of mouse  -cells was insensitive to 200  M tolbutamide
(1.14   0.11 vs. 1.04   0.14 pA/pF, n   16, P   0.05), as
initially reported by Göpel et al. (1999). This suggests
that Kslow current does not appear to be a mosaic of SK
and KATP currents using our standard conditions.
The Class III Antiarrythmic Drug AZ also Blocks Kslow 
Current in Single Mouse  -Cells
In heart cells, the class III antiarrythmic agent AZ blocks
both IKr and IKs delayed rectifying K  currents, the
former a fast, voltage-dependent K  channel, and the
Figure 1. Expression and block of Kslow by an SK channel blocker.
UCL 1684, a potent and selective nonpeptide SK blocker blocks
Kslow currents in mouse  -cells. Top traces (A and B) show repre-
sentative recordings of Kslow current. The peak of the Kslow tail
currents is denoted by arrows. The currents shown were elicited
using a burst pulse protocol (see MATERIALS AND METHODS)
in voltage clamp. (C) Dose–response curve of UCL 1684 on
Kslow. UCL 1684 suppressed Kslow current with an IC50 of 6.2 nM.
Data shown are mean   SEM, with n (number of experiments)
indicated in brackets. Curve was ﬁt with single binding site model.356 Calcium-activated K  Current in Islet  -Cells
latter a slowly activating K   channel (Busch et al., 1994;
Ohyama et al., 2001). HMR 1556 is a selective blocker of
IKs in heart cells (Gögelein et al., 2000). The antiarryth-
mic action of AZ is believed to occur due to prolonga-
tion of the cardiac action potential and increased rela-
tive refractoriness, both secondary to K  current block-
ade (Busch et al., 1994; Fermini et al., 1995; Salata and
Brooks, 1997; Karam et al., 1998). As conventional K 
channel blockers like TEA did not show selectivity for
Kslow, and because IKs in cardiac cells shows a similar slow
deactivation characteristic, we decided to test whether
two blockers of IKs affect the  -cell Kslow current. The
bath application of AZ to  -cells resulted in the revers-
ible and nearly complete suppression of Kslow current
(Fig. 2 A). The addition of 3  M AZ reduced Kslow cur-
rent density from 1.68   0.31 to 0.77  0.15 pA/pF (n  
5, P    0.05), and Kslow blockade typically reached a
steady-state level within 5 min. Fig. 2 B shows the dose–
response curve of AZ blockade of Kslow, whose ﬁt yielded
an IC50 of 3.2  M and a Bmax of 100% (n   5–8, P  
0.05), as shown in the ﬁgure. The IC50 for Kslow block by
HMR 1556 was 127.3 nM (unpublished data). The sensi-
tivity of Kslow to AZ and HMR 1556 was generally similar
to that reported for cardiac IKs channels (Busch et al.,
1994; Gögelein et al., 2000; Thomas et al., 2003).
The blockade of Kslow by AZ and HMR raised the pos-
sibility that IKs rather than SK channels might mediate
or at least contribute to mouse  -cell Kslow current. To
test this hypothesis, we isolated islets from mice lacking
either KCNQ1 or KCNE1 genes due to a global deletion
(Kupershmidt et al., 1999; Casimiro et al., 2001; Kondo
et al., 2003). It has been documented that IKs current in
heart cells is mediated by a heteromultimeric channel
consisting of a KCNQ1 channel subunit and a KCNE1
ancillary subunit (Robbins, 2001). The presence of
KCNE1 signiﬁcantly increases the amplitude and activa-
tion time constant of IKs in heterologous expression sys-
tems (Seebohm et al., 2001; Melman et al., 2004).
Figure 2. The class III antiarrythmic drug azimilide also blocked
Kslow currents in mouse  -cells. (A) Representative recordings
showing that AZ reversibly blocks Kslow current. (B) Dose–response
curve of AZ inhibition of Kslow. AZ suppressed Kslow current with an
IC50 of 3.2  M. Data shown are mean   SEM, with n (number of
experiments) indicated in parentheses. Curve was ﬁt with a single
binding site model.
Figure 3. (A)  -cells from KCNE1 null mice lacking cardiac type IKs delayed rectiﬁer K  channels also express AZ-sensitive Kslow currents.
Top traces show representative Kslow currents from KCNE1 ( / ) mouse  -cells, both  -cells from KCNE1 ( / ) and KCNE1 ( / )
mice are sensitive to AZ. Bottom bar graph shows no difference of mean Kslow currents in KCNE1 ( / ) and KCNE1 ( / ) mice
(n   38–45, P   0.05), AZ signiﬁcantly inhibited Kslow currents in both group mice (**, P   0.01, n   6). (B)  -cells from KCNQ1 null
mice lacking cardiac type IKs delayed rectiﬁer K  channels still have AZ-sensitive Kslow currents. Top traces show representative Kslow
currents from KCNQ1 ( / ) mouse  -cells. Both  -cells from KCNQ1 ( / ) and KCNQ1 ( / ) mice are sensitive to AZ. Bottom bar
graph shows no difference of mean Kslow currents in KCNQ1 ( / ) and KCNQ1 ( / ) (P   0.05, n   12), AZ signiﬁcantly inhibited
Kslow currents in both groups of mice (*, P   0.05, n   5).Zhang et al. 357
As shown in Fig. 3 (A and B), islet  -cells isolated
from global KCNE1 or KCNQ1 knockout mice that
lack cardiac IKs (Kupershmidt et al., 1999) still exhib-
ited slowly activating and deactivating, and AZ-sen-
sitive Kslow currents. The mean t1/2 of Kslow deactiva-
tion in wild-type  -cells was 1.9   0.2 s, n   16, and
was not signiﬁcantly different in  -cells from either
KCNQ1  /  or KCNE1  /  islet  -cells (n   16 or
n   24). The bar graphs shown in Fig. 3 (A and B)
conﬁrm that Kslow current density was not signiﬁcantly
reduced in  -cells from either the KCNQ1  /  or
KCNE1  /  mice. Furthermore, it is clearly appar-
ent that 3  M AZ retained its ability to inhibit Kslow
current despite the lack of IKs. This strongly suggests
that AZ does not inhibit Kslow by targeting channels
composed of KCNQ1/KCNE1, and that, by exten-
sion, IKs is unlikely to mediate Kslow current in pancre-
atic  -cells.
To determine whether AZ also blocked KATP, we test
its effect on  -cell KATP current recorded in whole cell
patch clamp conﬁguration. We found that whole cell
KATP conductance was unchanged by AZ. Thus, KATP
conductance varied from 3.35   0.36 to 3.30   0.39 nS
measured from  80 to  20 mV in the absence or pres-
ence of AZ, respectively, n   6). Whole cell KATP con-
ductance was activated by dialyzing single mouse  -cells
with a pipette solution lacking Mg-ATP. Taken together
with data showing that Kslow current was insensitive to
tolbutamide, these ﬁndings show that Kslow is not medi-
ated by KATP in our hands. Parenthetically, AZ also had
no effect on the amplitude of voltage-dependent Ca2 
current in  -cells (unpublished data).
AZ and UCL 1684 Block SK Channels Expressed in HEK Cells
Although AZ is known to interact with a variety of chan-
nels and receptors in other systems (for review see
Figure 4. (A) HEK 293 cells coexpressed SK3 and EGFP genes used in the study. Green ﬂuorescent cells were chosen to measure SK3
currents (left), and the ﬁgure on the right shows the same cells in bright ﬁeld. (B) UCL 1684 blocks SK3 channels expressed in HEK 293
cells. i and iii traces show the representative currents recorded at  80 mV (i) or  10 mV (iii) from 15 cells. Green ﬂuorescent cells were
selected and the SK3 currents were recorded using the whole cell patch clamp conﬁguration. As shown in ﬁgure, bath application of an SK
blocking solution containing 10 mM BaCl2 and 30 mM TEA-Cl, resulted in small basal currents. After replacing the external solution with
30 mM KCl, robust SK3 currents are observed (*, P   0.05; **, P   0.01, compared with the basal level). 10 nM UCL 1684 signiﬁcantly
inhibited this current at  80 mV (ii) or  10 mV (iiii) (#, P   0.05; ##, P   0.01, n   6, bottom bar graph). (C) SK3-mediated currents in
HEK 293 cells are also signiﬁcantly blocked by AZ (##, P   0.01, n   7).358 Calcium-activated K  Current in Islet  -Cells
Brooks et al., 2001), a direct interaction with SK chan-
nels has not been previously reported. We thus tested
the possibility that AZ inhibits Kslow by directly inhibit-
ing SK type channels. Cloned SK3 and eGFP genes
were cotransfected into HEK 293 cells using standard
techniques (see MATERIALS AND METHODS), and
cells exhibiting green ﬂuorescence were selected for
patching (Fig. 4 A, left). A bright ﬁeld image of these
cells is shown in Fig. 4 (right).
As shown in Fig. 4 B, control recordings made using
solutions containing 30 mM external KCl exhibited
large inward currents at  80 mV (Fig. 4 B, i and ii,
mean value of  46.1   6.9 pA/pF) and outward cur-
rents at  10 mV (Fig. 4 B, iii and iiii, mean value of
36.2   11.1 pA/pF). Current increased following estab-
lishment of the whole cell mode when pipettes con-
tained 1  M free calcium. To preserve cell viability while
recording large SK currents,  -cells were initially bathed
in a solution containing the reversible SK blockers Ba2 
and TEA to inhibit osmotic stress due to SK activation and
resulting large K  ﬂuxes. Following break in, Ba2  and
TEA were then washed off the cells and 30 mM KCl
added to the bath solution to measure SK current, and
to test the sensitivity of the current to UCL 1684 or AZ
(Wittekindt et al., 2004). The current measured in HEK
293 cells dialyzed with 1  M [Ca2 ]i reversed at  70
mV, near the calculated potassium equilibrium poten-
tial ( 80 mV, Shah and Haylett, 2000), and showed a
near-Nernstian shift when [K]o was increased from 5 to
30 mM (38 mV shift vs. 45 mV predicted).
As shown in Fig. 4 B (ii and iiii), SK3-mediated cur-
rent was reduced  60% by the addition of 10 nM UCL
1684 (from  46.1   6.9 to  18.0   2.0 pA/pF at  80
mV, or from 36.2   11.1 to 12.6   3.2 pA/pF at  10
mV, P   0.05, n   6). As shown in Fig. 4 C, the applica-
tion of 10  M AZ also signiﬁcantly inhibited SK3 cur-
rent  46% (from  55.5   12.2 to  29.0   6.9 pA/pF
at  80 mV or from 68.5   14.0 to 36.9   7.9 pA/pF at
 10 mV, P    0.01,  n     7). The direct blockade of
cloned SK3 current by either AZ or UCL 1684 supports
the hypothesis that both UCL1684 and AZ block Kslow
in single  -cells by inhibiting an SK type KCa current, al-
though one that is insensitive to apamin (see DISCUS-
SION). We believe this is the ﬁrst report that AZ blocks
SK-type K  channels.
Functional Role of Kslow in Mouse  -Cells and Islets
To elucidate the role of Kslow current in mouse islets, we
used UCL and AZ as probes for Kslow participation in
the physiological regulation of glucose-induced islet
electrical activity, [Ca2 ]i, and insulin secretion from
 -cells or islets.
As shown in Fig. 5, the application of 10 nM UCL
1684 or 3  M AZ to single mouse  -cells that were ﬁr-
ing rapid action potentials in 11.1 mM glucose resulted
in a reversible membrane depolarization and signiﬁ-
cantly increased action potential ﬁring. In the  -cells,
sporadic action potentials or fast bursting were ob-
served under control conditions (for detail of single
 -cells ﬁring properties, see Kinard et al., 1999; Zhang
et al., 2003). The addition of UCL 1684 depolarized
the cells and increased the frequency of the spikes (Fig.
5, top). In 13  -cells, 10 nM UCL 1684 depolarized  -cell
silent potential from  50.2   2.5 mV to  44.4   2.4
mV (P   0.01), and increased the spike frequency from
58.8   18.9 min 1 to 133.7   31.4 min 1 (P   0.01).
Similar results were obtained using micromolar con-
centrations of AZ, as shown in the bottom trace of Fig.
5. In eight cells, the addition of 3  M AZ depolarized
 -cell potential from  48.3   3.7 mV to  41.3   2.5 mV
(P   0.01) and increased spike frequency from 76.4  
25.0 min 1 to 146.6   44.5 min 1 (P   0.05). These
data suggest that Kslow helps maintain the resting mem-
brane potential of single  -cells, and acts as a brake to
limit cell ﬁring, as in other systems (Wolfart et al.,
2001). Decreased repolarization would also be ex-
pected if UCL 1684 inhibited rapid delayed recitifer
outward K  current (KV) in  -cells, but the application
of 10 nM UCL 1684 had no effect on whole cell KV cur-
rent in parallel studies (unpublished data). The data
are also in accord with our previous observation that
 -cells exhibiting larger Kslow currents tended to be more
hyperpolarized (Goforth et al., 2002). This would be
expected if Kslow contributed to the maintenance of the
hyperpolarized silent phase potential of  -cells, along
with KATP.
In mouse islets, the addition of 11.1 mM glucose re-
sults in the appearance of electrical bursting (Ashcroft
and Rorsman, 1989; Zhang et al., 2003). As shown in
Figure 5. Bath application of Kslow blockers in 11.1 mM glucose
depolarize mouse isolated  -cells and increase the frequency of
action potential ﬁring. The perforated patch clamp technique was
used to record the membrane potential of single mouse  -cells.
Cell 1 (top trace) shows a representative sample from 13 recordings
before and after bath addition of 10 nM UCL 1684. Cell 2 (bottom
trace) shows a representative sample from eight recordings before
and after bath application of 3  M AZ.Zhang et al. 359
Fig. 6 A, medium (top) as well as slow bursting islets
(bottom) were similarly affected by Kslow blockade.
Thus, the application of 6  M AZ to islets bathed in
11.1 mM glucose reversibly depolarized islets and in-
creased action potential frequency. While some fast
membrane repolarization could still be observed in the
presence of AZ (arrow; Fig. 6 A, bottom), these repolar-
izing events appeared to be much shorter than in the
absence of drug, and the mean silent phase potential
was signiﬁcantly depolarized by AZ (from  54.4   2.3
mV vs.  43.9   2.7 mV, n   13, P   0.001).
UCL 1684 or AZ addition also reproducibly modu-
lated the [Ca2 ]i responses of islets exposed to 11.1
mM glucose. Thus, UCL 1648 increased the [Ca2 ]i
level corresponding to the membrane silent phase
(solid line), and increased the frequency of islet
[Ca2 ]i oscillations (Fig. 6 B, representative of 10 is-
lets). Mean [Ca2 ]i increased from 269.4   18.8 nM to
328.6   16.2 nM after treatment with 100 nM UCL
(P   0.05). The application of 6  M AZ to islets in-
creased the frequency of islet [Ca2 ]i oscillations and
the mean [Ca2 ]i level from 288.4   18.3 to 322.6  
23.1 nM (n   7, P   0.05).
Blocking Kslow Potentiates Mouse Islet Insulin Secretion in a 
Glucose-dependent Manner
The increase in [Ca2 ]i we observed following Kslow
blockade suggested that glucose-dependent insulin se-
cretion might also be increased by UCL 1684 or AZ.
While 10 and 100 nM UCL 1684 had no effect on basal
insulin secretion (measured in 2.8 mM glucose (P  
0.05), these concentrations increased glucose-stimu-
lated insulin secretion from 722.3   42.7 to 919.4  
54.2 or 1096.0   54.2 pg · l 1 · islet 1 · h 1
, respectively
(Fig. 7 A, P   0.01, n   8).
AZ also potentiated glucose-dependent insulin secre-
tion as shown in Fig. 7 B. Thus, basal insulin release in
2.8 mM glucose was 264.7   19.7 pg · l 1 · islet 1 · h 1.
When glucose concentration was increased to 11.1 mM,
insulin release increased to 722.3   42.7 pg · l 1 ·
islet 1 · h 1. The addition of 3.0 or 10.0  M AZ signiﬁ-
cantly enhanced islet insulin release by 34.8% and
68.4%, respectively (Fig. 7 B, P  0.01, n   8).
The similar potentiating effects of these two struc-
turally unrelated Kslow blockers suggest that targeting
this channel may represent a new pharmacological
approach for increasing insulin release from the pan-
creas without also producing hypoglycemia (MacLeod,
2004). Thus, blockers of Kslow such as AZ and UCL 1684
could work in a similar manner to the KATP channel-
blocking sulfonylureas, as both drug types block a rest-
ing K  conductance, resulting in cell membrane depo-
larization, increased Ca2  uptake, and increased insulin
exocytosis (Ferner and Neil, 1988; Aguilar-Bryan et al.,
1995; Philipson and Steiner, 1995). However, in the
case of Kslow blockers, insulin secretion would only be
Figure 6. (A) Islets exposed to 6  M AZ in 11.1 mM glucose exhibited depolarized silent phase potential and increased bursting. Top,
response of a medium bursting islet to AZ; bottom, response of a slow bursting islet to AZ. Traces are representative of 14 islet recordings.
(B) UCL 1684 and AZ increase mean [Ca2 ]i in mouse islets. The acute application of 100 nM UCL 1684 or 6  M AZ to islets bathed in
11.1 mM glucose increased silent phase [Ca2 ]i, while the peak levels appeared to be unchanged. The traces shown are representative
samples of 10 islets from UCL 1684 group and seven islets from AZ group. Dotted lines indicate the silent phase levels of [Ca2 ]i.360 Calcium-activated K  Current in Islet  -Cells
ampliﬁed when glucose was already elevated, reducing
the possibility of hypoglycemia, a drawback of the sulfo-
nylureas (Ferner and Neil, 1988). Kslow blockade is ex-
pected to require elevated glucose for it to be effective,
since  -cell depolarization due to KATP closure by glu-
cose must ﬁrst occur for [Ca2 ]i to rise sufﬁciently to
activate Kslow (Göpel et al., 1999; Goforth et al., 2002).
Under basal condition, [Ca2 ]i would be too low to suf-
ﬁciently activate Kslow.
DISCUSSION
SK Channels Mediate Kslow Current in Mouse  -Cells
While there is agreement in the ﬁeld that Kslow is medi-
ated at least in part by a Ca2 -activated K  channel in
pancreatic   -cells, the speciﬁc channel involved has
been controversial. Thus, while the insensitivity of Kslow
to charybdotoxin, which blocks the large conductance
BK type KCa channels of  -cells (Kukuljan et al., 1991;
Li et al., 1999), speciﬁcally rules out mediation by
BK channels, SK mediation has been unclear because
apamin, a bee venom peptide that selectively blocks SK
but not BK channels, has yielded disparate results, with
one group reporting effects of the toxin on islet Ca2 
oscillations (Tamarina et al., 2003), while two other
groups reporting that Kslow current was insensitive to
apamin (Göpel et al., 1999; Goforth et al., 2002).
We thus considered other pharmacological agents in
an attempt to further clarify matters. The sensitivity
of Kslow current to the nonpeptide SK inhibitor UCL
1684, and its insensitivity to the IK(Ca) (or SK4) inhibi-
tor chlortrimazole (0.94   0.07 vs. 0.94   0.08 pA/pF,
n   10, P   0.05) suggests that Kslow current is medi-
ated at least in part by SK channels similar to SK1, 2,
or 3, although the  -cell isoform involved must be
apamin insensitive.
Further evidence in favor of Kslow mediation by SK
channels was obtained with AZ, which readily blocked
Kslow current and which up to now has been discussed
as a selective inhibitor of the slow delayed rectiﬁer cur-
rent in heart, IKs (Busch et al., 1994). We ruled out that
islet Kslow current included a contribution from a car-
diac-like IKs, as AZ-blockable Kslow current persisted in
islets obtained from KCNQ1 or KCNE1 null mice lack-
ing IKs, which in cardiac cells is formed by the coexpres-
sion of KCNQ1 and KCNE1 subunits (Barhanin et al.,
1996). Moreover, showing that AZ can directly block
heterologously expressed hSK3 channels in HEK cells
suggests SK mediation of Kslow current. However, the
apamin sensitivity of hSK3 suggests it is unlikely that
SK3 is the isoform that mediates Kslow in  -cells (Tama-
rina et al., 2003). The fact that the extended current–
voltage curves we observed in some native  -cells had
the pronounced inward rectiﬁcation expected of SK
currents (unpublished data; Soh and Park, 2001) fur-
ther supports the hypothesis that SK channels mediate
Kslow in  -cells.
We also brieﬂy considered the possibility that apa-
min-insensitive KCa channels such as those that mediate
the slow afterhyperpolarization of CNS neurons (sAHP;
Vogalis et al., 2003; Stocker et al., 2004) might be in-
volved in mediating  -cell Kslow current. However, this
seems to be unlikely given that the neuronal sAHP,
which is believed to be mediated by a non-SK type iso-
form is insensitive to the UCL compounds (Shah et al.,
2001; Bond et al., 2004). Furthermore, the kinetic
properties of sAHP would appear to be slower than for
 -cell Kslow current (Vogalis et al., 2003).
What SK Isoforms Mediate Kslow?
While it might appear paradoxical that Kslow could be
mediated by an apamin-insensitive SK isoform, recent
studies have revealed that alternative splicing of the SK
Figure 7. (A) UCL 1684 enhanced glucose-dependent insulin secretion from mouse islets. Islets were treated with different concentrations
of UCL 1684 for 1 h using either basal (2.8 mM) or high (11.1 mM) glucose. Data shown were collected from four mice. ***, P   0.001 vs.
2.8 mM glucose group. ##, P   0.01; ###, P   0.001 vs. untreated 11.1 mM glucose group. (B) AZ also increased insulin release from islets
in 11.1 mM glucose. Data shown were obtained using islets isolated from four different mice. ***, P   0.001 vs. 2.8 mM glucose group. ##,
P   0.01; ###, P   0.001 vs. untreated 11.1 mM glucose group.Zhang et al. 361
gene can yield splice variants that are relatively insensi-
tive to apamin, as we found for Kslow (e.g., SK3_ex4;
Wittekindt et al., 2004), and that combining different
SK subunits in a heteromultimeric assembly can modify
SK channel pharmacology (Benton et al., 2003; Mon-
aghan et al., 2004; D’hoedt et al., 2004). While we can-
not at present select among these possibilities, further
work is required to clone and sequence the  -cell–spe-
ciﬁc SK isoforms. A recent paper reported that SK1–4
are all expressed in islet tissue and  -cell lines, al-
though whether these isoforms are  -cell speciﬁc was
not determined (Tamarina et al., 2003).
The Effects of Selective Kslow Blockers Suggests that Kslow 
Participates in Islet Bursting
We found that either UCL 1684 or AZ inhibited Kslow
current in a dose-dependent manner in mouse  -cells,
leading to increased membrane depolarization, action
potential ﬁring, and, concomitantly, elevated [Ca2 ]i
and insulin secretion. These ﬁndings broadly support
the hypothesis that Kslow plays an important role in the
genesis of islet electrical activity, as has been proposed
(Göpel et al., 1999; Goforth et al., 2002) but not previ-
ously demonstrated experimentally. We found that Kslow
activation contributes to  -cell membrane potential
during the silent phase of bursting, and may play a role
in terminating the cyclic bursts of Ca2 -dependent ac-
tion potentials that drive Ca2  inﬂux and insulin secre-
tion in mouse islets. Similar ﬁndings were observed in
neurons following inhibition of slow Ca2 -activated cur-
rents like sAHP (El Manira et al., 1994; Ghamari-Lan-
groudi and Bourque, 2004). While the activation and
deactivation kinetics of Kslow are relatively brief given
the more prolonged nature of electrical bursting ob-
served in islets, modeling studies have previously shown
that fast Kslow may interact with slower process in the
 -cells (e.g., KATP via ATP/ADP changes; ER Ca2 ) to
mediate slower modes of electrical activity (Bertram et
al., 2000; Bertram and Sherman, 2004a,b). Kslow may
also display slower deactivation kinetics during more
prolonged phases of Ca2  inﬂux than provided experi-
mentally here. Alternatively, we cannot rule out that in
situ the kinetics of Kslow current are slower than we ob-
served in the isolated  -cells.
The Development of Novel Drugs To Block Kslow Could 
Represent a New Way To Increase Glucose-dependent 
Insulin Secretion in Diabetic Patients without also Causing 
Hypoglycemia
There is currently much interest in the islet ﬁeld in in-
vestigating novel targets for drugs that might increase
insulin secretion in a glucose-dependent manner (Mac-
Leod, 2004). Our work suggests that inhibition of Kslow
could be useful clinically, as Kslow appears to help con-
trol Ca2  inﬂux into the  -cell when glucose is elevated
and that its inhibitors signiﬁcantly enhance insulin se-
cretion. Targeting Kslow pharmacologically may thus
provide a novel, glucose-sensitive target for a new gen-
eration of antidiabetic agents.
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